These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27852165)

  • 41. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy.
    Agosti C; Borroni B; Archetti S; Akkawi NM; Padovani A
    Neurosci Lett; 2008 Oct; 443(3):228-31. PubMed ID: 18692116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does BDNF Val66Met Polymorphism Confer Risk for Posttraumatic Stress Disorder?
    Wang T
    Neuropsychobiology; 2015; 71(3):149-53. PubMed ID: 25925851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.
    Szabo AJ; Alosco ML; Miller LA; McGeary JE; Poppas A; Cohen RA; Gunstad J
    Psychogeriatrics; 2013 Dec; 13(4):206-12. PubMed ID: 24289461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction between BDNF Val66Met and childhood stressful life events is associated to affective memory bias in men but not women.
    van Oostrom I; Franke B; Rijpkema M; Gerritsen L; Arias-Vásquez A; Fernández G; Tendolkar I
    Biol Psychol; 2012 Jan; 89(1):214-9. PubMed ID: 22033217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
    Hashim HM; Fawzy N; Fawzi MM; Karam RA
    J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis.
    Gómez-Garre P; Huertas-Fernández I; Cáceres-Redondo MT; Alonso-Canovas A; Bernal-Bernal I; Blanco-Ollero A; Bonilla-Toribio M; Burguera JA; Carballo M; Carrillo F; Catalán-Alonso MJ; Escamilla-Sevilla F; Espinosa-Rosso R; Fernández-Moreno MC; García-Caldentey J; García-Moreno JM; García-Ruiz PJ; Giacometti-Silveira S; Gutiérrez-García J; Jesús S; López-Valdés E; Martínez-Castrillo JC; Martínez-Torres I; Medialdea-Natera MP; Méndez-Lucena C; Mínguez-Castellanos A; Moya M; Ochoa-Sepulveda JJ; Ojea T; Rodríguez N; Sillero-Sánchez M; Vargas-González L; Mir P
    Mov Disord; 2014 Jul; 29(8):1083-6. PubMed ID: 24925604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.
    Saarela MS; Lehtimaki T; Rinne JO; Huhtala H; Rontu R; Hervonen A; Roytta M; Ahonen JP; Mattila KM
    Folia Neuropathol; 2006; 44(1):12-6. PubMed ID: 16565926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Anxiety and polymorphism Val66Met of BDNF gene--predictors of depression severity in ischemic heart disease].
    Golimbet VE; Volel' BA; Kopylov FIu; Dolzhikov AV; Korovaitseva GI; Kasparov SV; Isaeva MI
    Kardiologiia; 2015; 55(1):9-13. PubMed ID: 26050483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
    Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease.
    Sampedro F; Marín-Lahoz J; Martínez-Horta S; Pagonabarraga J; Kulisevsky J
    Behav Brain Res; 2019 Oct; 372():112039. PubMed ID: 31202861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigating the Contribution of NPSR1, IL-6 and BDNF Polymorphisms to Depressive and Anxiety Symptoms in Hemodialysis Patients.
    Alshogran OY; Al-Eitan LN; Altawalbeh SM; Khalil AA; Alqudah MAY; Oweis AO; Aman HA; Alhawari HH
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109657. PubMed ID: 31132388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
    Zhang XY; Zhang WF; Zhou DF; Chen DC; Xiu MH; Wu HR; Haile CN; Kosten TA; Kosten TR
    Biol Psychiatry; 2012 Oct; 72(8):700-6. PubMed ID: 22695185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [No effect of the BDNF Val66Met polymorphism on cognitive deficit in patients with schizophrenia and on the risk of the disease in their relatives].
    Alfimova MV; Golimbet VE; Korovaitseva GI; Lezheiko TV; Gabaeva MV; Oleichik IV; Stolyarov SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):75-79. PubMed ID: 25909793
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer.
    Dooley LN; Ganz PA; Cole SW; Crespi CM; Bower JE
    J Affect Disord; 2016 Jun; 197():43-50. PubMed ID: 26967918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder.
    Moreira FP; Fabião JD; Bittencourt G; Wiener CD; Jansen K; Oses JP; Quevedo Lde Á; Souza LD; Crispim D; Portela LV; Pinheiro RT; Lara DR; Kaster MP; da Silva RA; Ghisleni G
    Psychiatr Genet; 2015 Oct; 25(5):201-7. PubMed ID: 26110341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Val66Met polymorphism in BDNF on attentional bias in an extroverted Chinese Han population.
    Gong P; Xi S; Li S; Cao G; Zhang P; Shen G; Zhang F; Shen Y; Ma H
    Acta Neurobiol Exp (Wars); 2013; 73(2):280-8. PubMed ID: 23823988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increase in serum brain-derived neurotrophic factor in met allele carriers of the BDNF Val66Met polymorphism is specific to males.
    Bus BA; Arias-Vasquez A; Franke B; Prickaerts J; de Graaf J; Voshaar RC
    Neuropsychobiology; 2012 Jun; 65(4):183-7. PubMed ID: 22538247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.